Monday, April 7, 2014

Global Growth In Social Gaming Market From 2013 to 2019

Transparency Market Research "Social Gaming Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global Social Gaming market is expected to reach a value of USD 17.40 billion by 2019, growing at a CAGR of 16.1% from 2013 to 2019. Growth in the usage of internet and social networking sites has spurred the growth of the games over the internet. The other factor being the growing demand of smartphones and tablet PCs. Asia Pacific was the largest contributor in social gaming market and accounted for a share of 45% in 2012. Decline in prices of mobile devices i.e. smartphones and tablets and easy access to internet has resulted in the growth of these games.
Browse Social Gaming Market Report with Full TOC at http://www.transparencymarketresearch.com/social-gaming-market.html
Among different types of revenue generation methods, virtual goods helped generate 60% of the revenue followed by advertisements in 2012. Continuous rise in the internet subscribers, increase social network accounts, demand for mobile devices and free and easy access to internet are some important factors driving the demand for social gaming globally. Ban on social networking sites in regions such as the Middle East and China has limited the growth of the market. People of age group 19 - 25 years has contributed largely to the growth of social games and is expected to grow at a CAGR of 17.3 % during the forecast period from 2013 - 2019. A major reason for the growing popularity of the social games among this age group is the readily available internet services in schools, colleges or homes.
Female is the largest gender segment that held a share of around 54% in 2012 followed by male with 46 % share in 2012. Demand for games by female is primarily driven by increase in usage of internet in the homes and the rise in demand of smartphones.
In terms of geographical regions, Asia Pacific represents largest market for social gaming and is expected to reach USD 7.59 billion by 2019. Huge population in the region has boosted the demand of mobiles and smartphones which in turn has compelled the game designers to develop games of the mobile devices.
The global social gaming market was dominated by Zynga Inc. in 2012. Other important players in the global social gaming market include Playdom, Rock You, Rovio and others.
The global social gaming market is segmented as below:

Social Gaming Market
By revenue generation

  • Virtual goods
  • Advertisements
  • Lead generation offers

By Gender

  • Male
  • Female

By Age Group

  • 13 - 18 years
  • 19 - 25 years
  • 26 - 35 years
  • 36 - 45 years
  • 46+ years

By geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)
Browse all Technology & Media Market Research Reports @http://www.transparencymarketresearch.com/technology-market-reports-8.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Web: http://www.transparencymarketresearch.com/

Wednesday, April 2, 2014

Growth Factors of the Organ Preservation Solutions Market



The organ preservation solutions market has been playing an important role in increasing the number of organ transplants. Basically, an organ preservation solution is a method that helps in preserving organs in a special place when they are no longer inside a human body. The preservation solutions make the organs vulnerable to the exterior environment present outside the human body. The organs that are removed from the human body are then preserved in specific preservative solutions for multifarious purposes such as development of drugs and biologics and organ transplant procedures and research and development.

Now-a-days, organ preservation solutions is widely utilized for preserving different organs such as liver and kidney because it is highly capable of preserving a variety of organs unlike the solutions HBS and Perfadexs. 

Major Categories in Organ Preservation Solutions

According to the global market data, the organ preservation solutions has been sectioned into nine major solutions including Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solution and others (Ross-Marshall Citrate Solutions, Celsior Solution, Phosphate-Buffered Sucrose Solution, ET-Kyoto, TranSend, HetaFreeze, MaPersol and CryoStor).

Various Organ Preservation Techniques

Many interesting medical techniques are acquired and implemented to preserve the organs in appropriate spaces. On the basis of organ preservation techniques, the market has been segmented into three categories namely hypothermic perfusion preservation (HPP), static cold storage (SCS) and others (that include normothermic preservation and oxygen insufflation techniques). However, unlike the static cold storage (SCS) technique which does not allow any type of continuous contact of the organ with the solution, the hypothermic perfusion preservation (HPP) technique is a much viable technique to adapt. It is a machine perfusion process that maintains a continuous supply to the organs required by the solution. This helps the organs to survive properly in the duration.

Value-Drive Growth Factors of the Organ Preservation Solutions Market

Considering the diseases and disorders spread amongst a variety of people across the world, rising incidences of organ failures in the patients has stirred the maximum demand for organ preservation solutions market. The organ preservation solutions market is primarily driven by organ failures that in turn necessitate organ transplant procedures. Worldwide, there are a number of patients that are highly eager to get an organ transplant done so that they live a smooth and stress-free life. Another factor that has stimulated the demand for the organ preservation solutions market is people’s lifestyle. Today, people are more addicted to surrounding themselves with a lifestyle full of fast-food consumptions, alcohol, and smoking. The extreme use of such life-threatening factors has affected the lives of thousands of people in the world.
It is also observed that rise in geriatric population in the developed areas such as U.K and U.S has further led to a rise in the demand for organ transplant procedures. Such regions, health-conditions, and viability from the time of organ donation to transplantation aspects have essentially propelled the growth of this particular market segment.

Supplementary - Growth Contributors

The rise in per capita healthcare expense and the advancing imbursement arrangements for the organ transplant procedures in different nations such as U.S, U.K, and India are auxiliary factors that have helped in the overall growth of the organ preservation solutions market. This would enable the patients to afford the medical procedures and reduce their medical expenses, as well as provide better healthcare services.

In addition, the growth of this market will also be driven with the emergence of technologically improved products such as Lifor. Lifor is termed as a blood surrogate that will clinically prove its effectiveness in saving and preserving human and veterinary organs with utmost safety.
The global market for organ preservation solutions has been predicted to grow at a CAGR rate of 16.5% during the forecast period 2013 to 2019, with a prediction for the market revenue to reach USD 204.9 million in the same forecast period. The geographically active regions that help in the growth of the organ preservation solutions market include Europe (49.96%), North America (42.23%), Asia-Pacific (5.66%), and RoW (2.15%) for 2012 (%).


Tuesday, April 1, 2014

: Global Life Sciences BPO Market to be Worth USD 596 Billion by 2019: Transparency Market Research



As the life sciences industry becomes increasingly competitive while being pressured by regulatory mandates, business process outsourcing (BPO) is being considered as an effective way to improve operational performance.


The market for life sciences BPO is comprised of two distinct entities offering their services to biotech and pharmaceutical companies—Contract Research Organizations and Contract Manufacturing Organizations.

But what are the factors that have given rise to a demand for life science BPO services? The pharma industry is constantly grappling with patent expirations, a pressure to develop low-cost drugs, and the growing uncertainty in economic conditions. Companies in this domain thus need to approach their core operations with singular focus. This is where life science BPO enterprises come into the picture with their support services. Pharma companies outsource various functions and non-core operations to third parties with a view to streamlining their value chain and cutting costs.

These partnerships are usually forged in the form of long-term contracts and partnerships with CMOs and CROs. Through these partnerships, pharma companies share costs right from drug discovery and development to licensing to approvals with the CMOs and/or CROs.

Pharma companies are also experiencing effective outcomes via life science BPOs; the latter leverage their experience, trained professionals, and latest technology to the advantage of the former.

On the other hand, life-science BPOs too have been driven by the pressure to compete and achieve profitability. They try to accomplish this by introducing novel strategies to offer their clients a competitive advantage. According to a market research report published by U.S.-based market research firm Transparency Market Research, the global life sciences BPO market is projected to record a compounded annual growth rate (CAGR) of 21.5% between 2013 and 2019. 

Experts predict a healthy growth rate thanks to factors such as increased R&D investments by pharmaceutical companies, a spike in the demand for generic drugs, as well as a myriad of block buster drugs nearing the end of their patents. Other factors that have created a favorable environment for life science BPO include stringent regulatory mandates and government pressure to develop affordable drugs.

The Contract Manufacturing Organizations Market

According to the market research report published by Transparency Market Research, the CMO life science services outsourcing currently holds the largest share in the Life Sciences BPO market. The growth in healthcare costs has subsequently caused an increased generic drug demand, which has in turn led to a spike in the demand for the services of pharmaceutical outsourcing enterprises. Moreover, most CMOs have full-fledged R&D centers that employ novel technologies to give their clients an edge.

The market for active pharmaceutical ingredients (API) is the largest within the CMO segment. With mounting regulatory compliance and stringent approval parameters, the outsourcing of manufacturing activities to CMOs has received a boost.

At a time when manufacturers are striving to stay abreast of the latest regulatory mandates and industry breakthroughs, continually investing in facility upgrades might not be possible. This is another factor that can be attributed to the surge in demand for outsourcing partners as manufacturers do not possesses every required technology or expertise in-house. In such scenarios, outsourcing not only gives them access to the latest manufacturing technologies, but also proves to be a cost effective strategy.

The Contract Research Organizations (CRO) Market

Over the past decade, there has been considerable growth in the outsourcing services offered by CROs. Many pharmaceutical companies have been struggling to find a balance between mounting research costs and profitability. This has led many of these firms to turn towards CROs as a feasible option. The vendors operating in the market currently offer a combination of various services such as research, regulatory co-ordination services, data management, website management, medical writing, protocol development and others.

In 2012, the largest segment within this market was drug discovery. A report by Transparency Market Research however projects that between 2013 and 2019, the highest growth will be seen in the clinical data management BPO services at the rate of 17.3%.

Growth Projections

It is estimated that the Life Sciences BPO Market will be worth USD 596 billion worldwide by 2019, according to the Transparency Market Research report. And, while North America held the largest share in this market in 2012 with a worth of USD 28.4 billion, future growth is expected to be the highest in the Asia Pacific region with an approximate growth rate of 21.2% driven by various factors such as low cost of labor, availability of a talent pool, a large patient population, and comparatively favorable regulatory policies.

Friday, March 28, 2014

Nanomedicine Market: An Overview of Growth Factors and Future Prospects



Nanomedicine is essentially based on the medical application of nanotechnology in diagnosing, treating and/or prevention of diseases and infections. Nanotechnology-based drugs and treatments are applied for treating cardiovascular, neurological, and oncology diseases.

Nanomedicine is based on the utilization of knowledge pertaining to various nanoparticles, their medical usages, and their actions within the human body.

There still exists considerable scope for research in this domain, and scientists are currently engaged in further studying the treatment-worthiness of a number of nanoparticles such as fullerenes, dendrimers, drug conjugates, and nano crystals.

It is important to note that this area of medicine is still in its nascent stage mainly because it is a niche research area and it receives comparatively less research funding.

Future prospects of the nanomedicine market

A research report by Transparency Market Research, a U.S.-based market research company, projects that the nanomedicine market will be largely driven by partnerships between global research firms and leading industry institutes. These collaborations will play a crucial part in attracting more investments. The report states that the global market for nanomedicine is projected to witness a compounded annual growth rate (CAGR) of 12.3% between 2013 and 2019.

Oncology – a significant segment within the nanomedicine market

According to the market research report by Transparency Market Research, oncology was the largest application segment within the nanomedicine market with a total share of 38%. This is attributed to the large scale focus on developing drugs and treatments for cancer, and the fact that approved nanomedicine drugs also exist in the market.

However, cardiovascular applications of nanomedicine are regarded as being the fastest-growing segment within the nanomedicine market. A large number of people being affected by cardiovascular problems worldwide, and the availability of various devices catering to the needs of this patient segment are growth influencers in this market.

In addition, there has been a perceptible increase in support from various governments in bolstering research as well as product approvals within the nanomedicine segment; with this support likely to continue, the market for nanomedicine will continue to grow.

The need for research, investment and collaboration in the nanomedicine market

In the coming years, it is expected that further collaborations between academic institutes as well as research firms will provided a much-needed boost to the role of nanomedicine in chronic disease treatment.

Research and breakthroughs could lead to the emergence of new treatments and technologies, with more bioavailability.

Other factors such as a growing demand and acceptance of targeted drug delivery (especially where neurological disorders are concerned) has created a larger market for nanomedicine.

On the other hand, the prevalence of cardiovascular diseases is on the rise, and this trend asks for the introduction of drugs that possess higher efficiency and better therapeutic properties. This is yet another need that will propel demand for nanomedicine products.

Nanomedicine has already met with some success in oncology, and researchers and market players alike are buoyed by this success. Having realized the efficacy of nanomedicine in oncology, it is likely that the interest shown by market players to commercialize products in this segment will only rise.

It is projected that cardiovascular treatments are likely to emerge as the fastest growing market within the nanomedicine market between 2013 and 2019.

Increased collaboration between academic and research institutes will prove favorable for the nanomedicine market. A noteworthy example of this would be the collaboration between Elan Corporation Plc and Abbott Laboratories for the development of the Tricor drug. This collaboration was key to helping both players lower cost associated with research and development.

Looking forward, market analysts expect that breakthroughs in nanomedicine will be crucial to the development of treatments and products for diseases such as diabetes, cancer, neurological disorders, and cardiovascular diseases.